Abstract 3144: Neuroglobin Inhibits Oxygen-Glucose Deprivation-induced Mitochondrial Permeability Transition Pore Opening in Primary Cultured Mouse Cortical Neurons
Zhanyang Yu, Ning Liu, Xiaoying Wang
Abstract
Zhanyang Yu, Ning Liu, Xiaoying Wang
Abstract
Background: Accumulating evidences from our laboratory and others have demonstrated that neuroglobin (Ngb) is protective against hypoxic/ischemic brain injury, thus targeting Ngb may be a novel approach for endogenous neuroprotection, but the molecular mechanisms remain undefined. Mitochondrial permeability transition pore (mPTP) opening is a key mitochondrial response to hypoxia/ischemia, followed by release of mitochondrial factors such as Cyt c and activation of Caspase-dependent apoptosis pathways. In this study, we test our hypothesis that Ngb inhibits OGD-induced mPTP opening in primary neurons. Method: Primary mouse cortical neurons were transduced with AAV-Ngb to achieve Ngb over-expression and Ngb-shRNA to achieve Ngb knockdown. At day 9 of culture, primary neurons were subjected to 4 hr OGD followed by reoxygenation. Neurotoxicity was measured after 20 hr reoxygenation by LDH release assay. mPTP opening was measured at 4 hr after reoxygenation by testing mitochondria swelling, NAD release and Cyt c release. NAD release was also measured using isolated mitochondria treated with OGD after incubation with recombinant Ngb protein. Results: (1) Four hour OGD followed by 20 hr reoxygenation caused 40±4.5% neuron death; Ngb overexpression significantly reduced the death rate to 18±5.2% (n=5, p<0.05). (2) Ngb-overexpression significantly reduced OGD-induced mitochondria swelling, and rescued OGD-induced mitochondrial NAD release (mitochondrial NAD content 4±0.56 nmol/mg protein at normoxia, 2.1±0.35 nmol/mg prot. after OGD, 3.4±0.46 nmol/mg prot. in Ngb-overexpressing group after OGD) (n=4, p<0.05). (3) Ngb-overexpression significantly reduced OGD-induced Cyt c release from mitochondria to 0.43±0.08 fold (n=3, p<0.05). (4) Incubation with recombinant Ngb significantly reduced OGD-induced mitochondria NAD release in isolated mitochondria (mitochondrial NAD content 3.5±0.46 nmol/mg protein at normoxia, 1.8±0.32 nmol/mg prot. after OGD, 3.0±0.45 nmol/mg prot. in Ngb-overexpressing group after OGD) (n=4, p<0.05). (5) Ngb knockdown significantly increased OGD-induced neuron death from 40±4.5% to 56.4± 7.2%, and worsened OGD-induced mitochondria NAD release, but these changes were rescued by CsA, an mPTP inhibitor (n=3, p<0.05). (6) Co-IP detected protein interaction between Ngb and VDAC, an mPTP component, and the interaction was increased after OGD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: Accumulating evidences from our laboratory and others have demonstrated that neuroglobin (Ngb) is protective against hypoxic/ischemic brain injury, thus targeting Ngb may be a novel approach for endogenous neuroprotection, but the molecular mechanisms remain undefined. Mitochondrial permeability transition pore (mPTP) opening is a key mitochondrial response to hypoxia/ischemia, followed by release of mitochondrial factors such as Cyt c and activation of Caspase-dependent apoptosis pathways. In this study, we test our hypothesis that Ngb inhibits OGD-induced mPTP opening in primary neurons. Method: Primary mouse cortical neurons were transduced with AAV-Ngb to achieve Ngb over-expression and Ngb-shRNA to achieve Ngb knockdown. At day 9 of culture, primary neurons were subjected to 4 hr OGD followed by reoxygenation. Neurotoxicity was measured after 20 hr reoxygenation by LDH release assay. mPTP opening was measured at 4 hr after reoxygenation by testing mitochondria swelling, NAD release and Cyt c release. NAD release was also measured using isolated mitochondria treated with OGD after incubation with recombinant Ngb protein. Results: (1) Four hour OGD followed by 20 hr reoxygenation caused 40±4.5% neuron death; Ngb overexpression significantly reduced the death rate to 18±5.2% (n=5, p<0.05). (2) Ngb-overexpression significantly reduced OGD-induced mitochondria swelling, and rescued OGD-induced mitochondrial NAD release (mitochondrial NAD content 4±0.56 nmol/mg protein at normoxia, 2.1±0.35 nmol/mg prot. after OGD, 3.4±0.46 nmol/mg prot. in Ngb-overexpressing group after OGD) (n=4, p<0.05). (3) Ngb-overexpression significantly reduced OGD-induced Cyt c release from mitochondria to 0.43±0.08 fold (n=3, p<0.05). (4) Incubation with recombinant Ngb significantly reduced OGD-induced mitochondria NAD release in isolated mitochondria (mitochondrial NAD content 3.5±0.46 nmol/mg protein at normoxia, 1.8±0.32 nmol/mg prot. after OGD, 3.0±0.45 nmol/mg prot. in Ngb-overexpressing group after OGD) (n=4, p<0.05). (5) Ngb knockdown significantly increased OGD-induced neuron death from 40±4.5% to 56.4± 7.2%, and worsened OGD-induced mitochondria NAD release, but these changes were rescued by CsA, an mPTP inhibitor (n=3, p<0.05). (6) Co-IP detected protein interaction between Ngb and VDAC, an mPTP component, and the interaction was increased after OGD.
Key concepts: Neuroglobin, Mitochondrial permeability transition pore, Neuroprotection, MPTP, Mitochondrion, Cytochrome c, Apoptosis, NAD+ kinase